Pinnacle Financial Group, Inc.’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
Other funds holding AUTL
Pinnacle Financial Group, Inc.'s AUTL Position: Q3 2026 in Review
Pinnacle Financial Group, Inc. opened a new position in Autolus Therapeutics (AUTL) in Q3 2026: 1,000 shares worth $1.94K. The stake represents ﹤0.01% of the portfolio and ranks #1993 among its holdings.
90 funds tracked by Wall St. Rank hold AUTL as of Q3 2026.
- Pinnacle Financial Group, Inc. held 1,000 shares of Autolus Therapeutics worth $1.94K as of Q3 2026.
- Autolus Therapeutics was a new Pinnacle Financial Group, Inc. position in Q3 2026.
- Autolus Therapeutics made up ﹤0.01% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #1993 holding.
- 90 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q3 2026.
Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.